Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

Adeno-associated virus vector available for licensing from NIH

Aug. 3, 2000

Licensing opportunity from NIH: AAV4 and its use for gene delivery

Aug. 3, 2000

Licensing opportunity from NIH: methods of gene targeting

Aug. 3, 2000

New technology may improve safety in testing of adenovirus-based gene therapies

Aug. 3, 2000

Millennium and Aventis initiate major strategic alliance

Aug. 1, 2000

Rat studies support Cereport as an effective means of enhancing carboplatin delivery

July 31, 2000

CIMA licenses DuraSolv dosage form to Schwarz

July 27, 2000

Schein licenses ML Laboratories' Clickhaler in Canada

July 27, 2000

Substance from spider venom is first to block stretch-activated channels

July 24, 2000

Pharmacopeia identifies active compounds in lead discovery program with Roche Bioscience

July 19, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 29, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 29, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...